루테리온 그룹은 EU QP 선언을 갖춘 GMP 등급 임상시험용 의약품 생산 역량을 확보하고 있습니다. 글로벌 개발 네트워크는 중개연구와 비임상 개발, 임상 조정, 향후 생산 확대를 뜻받침도록 구성되었습니다.
GMP-grade investigational medicinal product manufacturing capabilities supporting nonclinical and clinical supply through affiliated operations.
Manufacturing capabilities supported by EU Qualified Person (QP) declaration for investigational medicinal product supply.
Planned future manufacturing and GLP/GMP laboratory expansion supporting the group's regional development network.